<DOC>
	<DOCNO>NCT01541670</DOCNO>
	<brief_summary>The purpose study determine safety tolerability Anti-MIF Antibody subject lupus nephritis .</brief_summary>
	<brief_title>Safety Study Anti-Macrophage Migration Inhibitory Factor ( Anti-MIF ) Antibody Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Signed date write informed consent obtain subject Males female age 18 year old time screen Established diagnosis systemic lupus erythematosus ( SLE ) accord American College Rheumatology classification criterion Documented renal biopsy evidence proliferative glomerulonephritis prior screen Urine proteintocreatinine ratio &gt; 0.5 ( mg/mg ) Any significant health problem lupus lupus nephritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>